日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

B cell phenotypes in patients with rheumatoid arthritis relapsing after rituximab: expression of B cell-activating factor-binding receptors on B cell subsets.

利妥昔单抗治疗后复发的类风湿性关节炎患者的 B 细胞表型:B 细胞亚群上 B 细胞激活因子结合受体的表达

Becerra E, De La Torre I, Leandro M J, Cambridge G

Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study

肌痛性脑脊髓炎/慢性疲劳综合征患者的扩展B细胞表型:一项横断面研究

Mensah, F; Bansal, A; Berkovitz, S; Sharma, A; Reddy, V; Leandro, M J; Cambridge, G

Effect of rituximab on B cell phenotype and serum B cell-activating factor levels in patients with thrombotic thrombocytopenic purpura.

利妥昔单抗对血栓性血小板减少性紫癜患者B细胞表型和血清B细胞激活因子水平的影响

Becerra E, Scully M A, Leandro M J, Heelas E O, Westwood J-P, De La Torre I, Cambridge G

Effects of rituximab-based B-cell depletion therapy on skin manifestations of lupus erythematosus--report of 17 cases and review of the literature

利妥昔单抗B细胞清除疗法对红斑狼疮皮肤表现的影响——17例病例报告及文献复习

Hofmann, S C; Leandro, M J; Morris, S D; Isenberg, D A

Translational Mini-Review Series on B Cell-Directed Therapies: The pathogenic role of B cells in autoantibody-associated autoimmune diseases--lessons from B cell-depletion therapy

关于B细胞靶向疗法的转化医学小型综述系列:B细胞在自身抗体相关自身免疫性疾病中的致病作用——来自B细胞清除疗法的启示

Leandro, M J; de la Torre, I

Repeated B cell depletion in treatment of refractory systemic lupus erythematosus

反复进行B细胞清除治疗难治性系统性红斑狼疮

Ng, K P; Leandro, M J; Edwards, J C; Ehrenstein, M R; Cambridge, G; Isenberg, D A

Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion

22例接受B淋巴细胞清除治疗的类风湿性关节炎患者的临床结果

Leandro, M J; Edwards, J C W; Cambridge, G